The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation determined the reported difficulties appear to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|
It was reported that the procedure was to treat a heavily calcified, moderately tortuous mid left anterior descending artery that is 90% stenosed.After ablation a non-abbott 2.75x15mm balloon was used to additionally dilate the lesion.The 3.0x18mm xience skypoint stent delivery system (sds) was advanced to the lesion and resistance was noted with the anatomy.During an attempt to deploy, the balloon ruptured at 5 atmospheres.The stent was not deployed; therefore, the sds was removed.Another 2.75x15mm non-abbott balloon was used to dilate the lesion again, a non-abbott stent was implanted and 3.0x15mm non-abbot balloon was used to successfully complete the procedure.There was no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
|